Healthcare provider profile · identity verified

Philip A Neiderer, DO

Internal Medicine · CARLISLE, PA · NPI 1922093509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	964	265
Losartan Potassium	Losartan Potassium	517	146
Amlodipine Besylate	Amlodipine Besylate	506	150
Omeprazole	Omeprazole	504	141
Rosuvastatin Calcium	Rosuvastatin Calcium	489	133
Levothyroxine Sodium	Levothyroxine Sodium	485	125
Lisinopril	Lisinopril	393	108
Metoprolol Succinate	Metoprolol Succinate	313	81
Sertraline Hcl	Sertraline Hcl	270	70
Metformin Hcl	Metformin Hcl	232	61
Simvastatin	Simvastatin	230	64
Jardiance	Empagliflozin	216	40
Metformin Hcl Er	Metformin Hcl	214	65
Pravastatin Sodium	Pravastatin Sodium	200	66
Furosemide	Furosemide	196	59
Carvedilol	Carvedilol	179	51
Escitalopram Oxalate	Escitalopram Oxalate	173	47
Hydrochlorothiazide	Hydrochlorothiazide	171	51
Eliquis	Apixaban	169	34
Alendronate Sodium	Alendronate Sodium	167	48
Pioglitazone Hcl	Pioglitazone Hcl	163	47
Spironolactone	Spironolactone	163	45
Pantoprazole Sodium	Pantoprazole Sodium	161	49
Trazodone Hcl	Trazodone Hcl	161	44
Tramadol Hcl	Tramadol Hcl	158	33
Tamsulosin Hcl	Tamsulosin Hcl	148	41
Duloxetine Hcl	Duloxetine Hcl	143	30
Atenolol	Atenolol	138	38
Prednisone	Prednisone	132	80
Potassium Chloride	Potassium Chloride	127	32
Gabapentin	Gabapentin	126	40
Glimepiride	Glimepiride	122	34
Ezetimibe	Ezetimibe	121	33
Synthroid	Levothyroxine Sodium	116	29
Xarelto	Rivaroxaban	110	17
Citalopram Hbr	Citalopram Hydrobromide	108	25
Clopidogrel	Clopidogrel Bisulfate	108	28
Mirtazapine	Mirtazapine	106	23
Metoprolol Tartrate	Metoprolol Tartrate	105	28
Esomeprazole Magnesium	Esomeprazole Magnesium	99	26
Lorazepam	Lorazepam	99	35
Allopurinol	Allopurinol	97	26
Donepezil Hcl	Donepezil Hcl	95	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	21
Albuterol Sulfate Hfa	Albuterol Sulfate	86	37
Famotidine	Famotidine	82	25
Buspirone Hcl	Buspirone Hcl	81	21
Topiramate	Topiramate	77	26
Mounjaro	Tirzepatide	69	13
Fluoxetine Hcl	Fluoxetine Hcl	67	18
Alprazolam	Alprazolam	64	18
Hydralazine Hcl	Hydralazine Hcl	64	15
Montelukast Sodium	Montelukast Sodium	64	20
Venlafaxine Hcl Er	Venlafaxine Hcl	59	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	16
Finasteride	Finasteride	57	15
Fluticasone Propionate	Fluticasone Propionate	52	25
Ibandronate Sodium	Ibandronate Sodium	52	17
Ipratropium Bromide	Ipratropium Bromide	50	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	13
Meloxicam	Meloxicam	49	18
Bumetanide	Bumetanide	47	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	14
Glipizide Er	Glipizide	46	11
Januvia	Sitagliptin Phosphate	45	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	45	14
Valsartan	Valsartan	41	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	12
Propranolol Hcl	Propranolol Hcl	38	suppressed
Valacyclovir	Valacyclovir Hcl	38	14
Propranolol Hcl Er	Propranolol Hcl	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Klor-Con M20	Potassium Chloride	35	12
Pregabalin	Pregabalin	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Sucralfate	Sucralfate	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Baclofen	Baclofen	31	suppressed
Digoxin	Digoxin	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Ramipril	Ramipril	30	suppressed
Amoxicillin	Amoxicillin	28	22
Celecoxib	Celecoxib	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Tolterodine Tartrate Er	Tolterodine Tartrate	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Irbesartan	Irbesartan	27	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	26
Indapamide	Indapamide	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	22	16
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Trulicity	Dulaglutide	21	suppressed
Diazepam	Diazepam	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Azithromycin	Azithromycin	19	19
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	15
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	17	suppressed
Linzess	Linaclotide	17	suppressed
Ozempic	Semaglutide	17	suppressed
Risedronate Sodium	Risedronate Sodium	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Buprenorphine	Buprenorphine	15	suppressed
Cephalexin	Cephalexin	15	13
Colchicine	Colchicine	15	suppressed
Estradiol	Estradiol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Nyamyc	Nystatin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Ibuprofen	Ibuprofen	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Invokana	Canagliflozin	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Primidone	Primidone	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Metaxalone	Metaxalone	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nystatin	Nystatin	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error